GeneGo Collaborates With University of Illinois at Urbana-Champaign to Include Bovine...

GeneGo Collaborates With University of Illinois at Urbana-Champaign to Include
Bovine Species Into MetaCore(TM)

ST. JOSEPH, Mich., Jan. 15 /PRNewswire/ -- GeneGo, Inc., a leading
provider of software and databases for systems biology, today announced they
will include bovine orthologs in the next release of MetaCore, in
collaboration with University of Illinois Urbana-Champaign whom identified the
matching bovine-mouse-rat-human orthologous pairs. The latest version MetaCore
4.5 already includes mouse, rat, fly, worm, yeast, chicken, chimpanzee, Rhesus
Macaque, dog, and Malaria plasmodium, making MetaCore the broadest platform
available for non-human species research. MetaCore also has a unique rat and
mouse specific interaction database called MetaRodent.
"We are happy to collaborate with UIUC on inclusion of bovine orthologs
into MetaCore. They did a superb job of ortholog identification," said Tatiana
Nikolskaya, President of GeneGo. "With the rapid advance of sequencing
technology, new eukaryotic genomes are becoming available at an increasing
rate, and each genome comes with an academic research community. And as each
community requests tools for functional analysis of their organism of choice,
we see an increasing demand for expansion of the list of species in the
database."
"GeneGo is definitely leading the way for species coverage," said Julie
Bryant, VP of Business Development. "We provide more species and unique
interaction databases for mouse and rat that will grow as we continue to
innovate."
Harris Lewin, Principal Investigator and Director of the Institute for
Genomic Biology at UIUC had this to say: "We were very pleased to work with
the team at GeneGo on the identification of cattle orthologs. My group feels
that MetaCore is currently the premier product for data mining and pathway
analysis. The addition of bovine orthologs of human, mouse and rat genes to
MetaCore will make the recently sequenced cattle genome more accessible for
functional genomics and systems biology."
About GeneGo
GeneGo develops systems biology technology for life science research. The
original computational MetaDiscovery(TM) platform allows an integration and
expert analysis of different kinds of experimental data (mRNA expression,
proteomics, metabolomics, microRNA assays and other phenotypic data) and
relevant bioactive chemistry (metabolites, drugs, other xenobiotics) within
the framework of curated biological pathways and networks. GeneGo's flagship
product, MetaCore 4.5(TM), assists pharmaceutical scientists in the areas of
target selection and validation, identification of biomarkers for disease
states and toxicology. The second product, MetaDrug 4.5(TM) is designed for
prediction of human metabolism, toxicity and biological effects for novel
small molecules compounds. MetaBase(TM) represents the knowledge base for
MetaCore. For more information, please visit the company's web site at
http://www.genego.com
MetaCore(TM), MetaBase(TM), MetaDrug(TM), MetaLink(TM), MetaDiscovery(TM),
MetaTox(TM), MetaMiner(TM) and 1-2-3 Workflow(TM) are trademarks of GeneGo,
Inc.
SOURCE GeneGo, Inc.

Julie Bryant, VP Business Development and Marketing of GeneGo, Inc.,
+1-858-756-7996, julie@genego.com